Transaction DateRecipientSharesTypePriceValue
19th November 2020Clifford Sosin1,600,000Open or private purchase$4.00$6,399,840.00
18th November 2020Kirk Somers778Exercise of derivative$20.00$15,560.00
16th November 2020Scott D. Grimes1,100Open or private sale$114.55$126,005.00
16th November 2020Scott D. Grimes900Open or private sale$113.83$102,447.00
13th November 2020David Leslie Adams4,800Open or private sale$108.82$522,336.00
13th November 2020David Leslie Adams23,750Exercise of derivative$50.04$1,188,450.00
13th November 2020Andrew Christiansen3,250Open or private sale$112.54$365,755.00
13th November 2020David Leslie Adams14,550Open or private sale$112.11$1,631,200.50
13th November 2020David Leslie Adams700Open or private sale$111.01$77,707.00
13th November 2020David Leslie Adams848Open or private sale$109.49$92,847.52
Cardlytics
Cardlytics logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 6/10.


Cardlytics, Inc. engages in the development of marketing solutions through its purchase intelligence platform. It operates through the Cardlytics Direct and Other Platform Solutions segments. The company was founded on June 26, 2008 and is headquartered in Atlanta, GA.


Ticker: CDLX
Sector: Communication Services
Industry: Internet Content & Information
SEC Central Index Key (CIK): 1666071
Employees: 402
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals
Cash at Carrying Value: $98 M (0%)
Assets, Current: $146 M (-25%)
Property, Plant and Equipment, Net: $13 M (0%)
Other Assets, Noncurrent: $2 M (0%)
Assets: $183 M (-18%)
Long-term Debt, Current Maturities: $24 Th (0%)
Accounts Payable, Current: $1 M (-4%)
Accrued Liabilities, Current: $3 M (-45%)
Liabilities, Current: $42 M (-45%)
Long-term Debt, Excluding Current Maturities: $0 (-100%)
Liabilities: $53 M (-35%)
Common Stock, Value, Issued: $8 Th (0%)
Common Stock, Shares, Issued: $26 M (14%)
Additional Paid in Capital, Common Stock: $500 M (3%)
Retained Earnings (Accumulated Deficit): $372 M (9%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $3 M (106%)
Stockholders' Equity (Parent): $130 M (0%)
Liabilities and Equity: $183 M (-18%)
Revenue: $28 M (-61%)
Research and Development: $4 M (0%)
Sales and Marketing: $10 M (0%)
General and Administrative Expenses: $12 M (0%)
Restructuring Charges: $400 Th (-55%)
Operating Income/Loss: $20 M (-37%)
Other Income, net: $20 Th (0%)